Showing results (31-40 of 38) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2024
Fraction Dose Escalation of Hypofractionated Radiotherapy with Concurrent Chemotherapy and Subsequent Consolidation Immunotherapy in Locally Advanced Non-Small Cell Lung Cancer: A Phase I StudyRui Zhou, FangJie Liu, HongMei Zhang, et al.Eclinicalmedicine|April 17, 2025
Safety and efficacy of neoadjuvant toripalimab plus chemotherapy followed by chemoradiotherapy for locally advanced esophageal squamous cell carcinoma in China (GASTO 1071): a non-randomised, two-cohort, phase 2 trialFangJie Liu, DaQuan Wang, YuMing Rong, et al.Clinical and Translational Radiation Oncology|March 13, 2023
An exploratory analysis of MR-guided fractionated stereotactic radiotherapy in patients with brain metastasesShouliang Ding, Biaoshui Liu, Shiyang Zheng, et al.Eclinicalmedicine|April 24, 2026
Fraction dose escalation of split-course concurrent chemoradiotherapy following induction chemo-immunotherapy in unresectable locally advanced oesophageal squamous carcinoma in China (GASTO-10102): a single-centre phase 1 studyFangJie Liu, DaQuan Wang, GuangYu Luo, et al.Journal for Immunotherapy of Cancer|June 23, 2024
Correlation of Ktrans derived from dynamic contrast-enhanced MRI with treatment response and survival in locally advanced NSCLC patients undergoing induction immunochemotherapy and concurrent chemoradiotherapyDaQuan Wang, SongRan Liu, Jia Fu, et al.Cancer|December 15, 2025
Magnetic resonance-guided split-course hypo-fractionated radiotherapy with concurrent chemotherapy and consolidative immunotherapy in locally advanced non-small cell lung cancer: A single arm, phase 2 studyPengXin Zhang, DaQuan Wang, ShaoHan Yin, et al.Eclinicalmedicine|April 18, 2025
Efficacy and safety of online adaptive magnetic resonance-guided fractionated stereotactic radiotherapy for brain metastases in non-small cell lung cancer (GASTO-1075): a single-arm, phase 2 trialShiyang Zheng, Shouliang Ding, Biaoshui Liu, et al.Cancer Medicine|June 16, 2023
Efficacy and cost-effectiveness analysis of pretreatment percutaneous endoscopic gastrostomy in unresectable locally advanced esophageal cancer patients treated with concurrent chemoradiotherapy (GASTO 1059)XinLei Ai, PengXin Zhang, XinMin Xie, et al.Pageof 4